Does Somatostatin Decrease Hemorrhage From Injured Liver in Rats?

Year 2009, Volume: 26 Issue: 1, 42 - 46, 06.12.2010

Bülent Akçora Enes M. Altuğ İyad Fansa Vedat Nisanoglu

Abstract

In portal hypertensive patients, somatostatin (SMT) and octreotide have been widely used to decrease variceal bleeding because of its splanchnic hypoperfusion effect. The aim of this study was to explore the effects of somatostatin treatment for decreasing blood loss of uncontrolled liver hemorrhage model in rats.Twenty-one male rats were divided into 3 groups including group 1; non-treatment, group 2; isotonic saline infusion and group 3; isotonic saline plus SMT infusion. Intra-abdominal bleeding was induced by transection of median lobe of liver. Mean arterial pressures (MAP), amount of intra-peritoneal blood collection and hematocrit (Hct) changes were evaluated for 60 minutes.There was no difference in the MAP changes between the groups until 25th minute. Thereafter, MAP remained similar in the group 1 while gradually increased (P< 0.05) in the group 2 and 3. There was no statistically significant difference between the groups 2 and 3. End of study, the highest Hct value was determined in the nontreatment group (41.0 ± 3.26 %) and it significantly different from other two groups. We found increase of Htc value in the group 3 (32.3 ± 2.75 %) when compared with group 2 (29.7 ± 4.19 %), but it was not statistically significant. The highest intra-peritoneal blood volume was determined in group 2. We found decrease of the hemorrhage in the group 3 when compared with the group 2, but it was not statistically significant. Somatostatin using has a tendency, although not statistically significant, to decrease of intraperitoneal hemorrhage from liver in the rat model.

Keywords

-

References

• American Collage of Surgeons, 1997. Committee on Trauma.Advanced Trauma Life Support Course for Physicians. Chicago: American Collage of Surgeons. 87–107.
• Bickell, W.H., Bruttig, S.P., Milnamow, G.A., et al., 1991. The detrimental effects of intravenous crystaloid after aortotomy in swine. Surgery. 110, 529–536.
• Carlsson, P.O., 1994. The long-acting somatostatin analogue octreotid decreases pancreatic islet blood flow in rats. Pancreas. Jansson, L.,. 9, 361–364.
• Cerini, R., Lee, S.S., Hadengue, A., et al., 1998. Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension. Gastroenterology. 94, 703–708.
• Cirera, I., Feu, F., Luca, A., et al., 1995. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology. 22, 106–111.
• Deitch, E.A., 1990. The role of intestinal barrier failure and bacterial translocation in the development systemic infection and multiple organ failure. Arch. Surg. 125, 403–404.
• Eriksson, L.S., Brundin, T., Soderlund, C., Wahrne, J., 1987. Haemodynamic effects of long-acting somatostatin analogue in patients with liver cirrhosis. Scand. J. Gastroenterol. 22, 919–925.
• Garcia-Manzano, A., Gonzales-Llaven, J., Lemini, C., 2001. Standardization of rat blood clotting tests with reagents used for humans. Proc. West. Pharmacol. Soc. 44, 153–155.
• Gross, D., Landau, E.H., Assalia, A., et al., 1998. Is hypertonic saline resuscitation safe in uncontrolled hemorrhagic shock. J Trauma. 28, 751–756.
• Holcomb, J.B., McClain, J.M., Pusateri, A.E., et al., 2000. Fibrin sealant foam sprayed directly on liver injuries decreases blood loss in resuscitated rats. J Trauma. 49, 246–250.
• Hoyt, D.B., Bulger, E.M., Knudson, M.M., et al., 1994. Death in the operating room: an analysis of a multi-center experience. J. Trauma. 37, 426–432.
• Jenkins, S.A., Poulianos, G., Coraggio, F., 1998. Somatostatin in the treatment of non-variceal upper gastrointestinal bleeding. Dig. Dis. 16, 214–224.
• Kowalenko, T., Stern, S.A., Dronen, S.C., et al. 1992. Improved outcome with hypotensive resuscitation of uncontrolled hemorrhagic shock. J. Trauma. 33: 349–353.
• Krausz, M.M., Bashenko, Y., Hirsh, M., Crystalloid and colloid resuscitatin of uncontrolled hemorrhagic shock following massive splenic injury. Shock. 16, 383–388
• Lee, C.C., Chang, I.J., Yen, Z.S., et al., 2007. Delayed fluid resuscitation in hemorrhagic shock induce proinflammatory cytokine response. Ann. Emerg. Med. 49, 37–44.
• Lin, H.C., Tsai, Y.T., Lee, F.Y., et al., 1992. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology. 103, 229–234.
• Matsuoka, T., Hildreth, J., Wisner, D.H., 1995. Liver injury as a model of uncontrolled hemorrhagic shock: resuscitation with different hypertonic regimens. J. Trauma. 39, 674–680.
• Palazon, J.M., Such, J., Sanchez-Paya, J., et al., 2006. A comparison of two different dosages of somatostatin combined with sclerotherapy for the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Rev. Esp. Enferm. Dig. 98, 249–254.
• Rafie, A.D., Rath, P.A., Michael, M.W., et al., 2004. Hypotensive resuscitation of multiple hemorrhages using crystalloid and colloids. Shock. 22, 262–269.
• Saruc, M., Can, M., Kucukmetin, N., et al., 2003. Somatostatin infusion and hemodynamic changes in patients with non-variceal upper gastrointestinal bleeding: a pilot study. Med. Sci. Monit. 9, PI84–187.
• Scannell, G., Clark, L., Waxman, K., 1992. Regional flow during experimental hemorrhage and crystalloid resuscitation. Persistence